Purified Cre recombinase protein Introduced directly Into cultured mammalian cells by lipofection catalyzes both site-specific chromosomal Integration of a cotransfected lox targeting vector and precise excision of genomic DNA flanked by directly repeated lox sites. This procedure eliminates the need to transfect cre expression plasmids to activate recombination at lox sites. We used this simplified procedure to investigate the effect on targeting efficiency of both lox vector design and chromosomal position of the lox target. We show that such chromosomal position effects can exert at least a 50-fold per lox target difference in targeting efficiency in a human osteosarcoma cell line.
INTRODUCTION
The 38 kDa Cre recombinase from bacteriophage PI catalyzes site specific recombination at loxP sites in both prokaryotic (1) and eukaryotic cells (2, 3) . In addition to Cre, a number of other site specific recombinases have been shown to be active in heterologous eukaryotic cells (4) (5) (6) (7) . These recombinases catalyze defined recombination events at pre-engineered sites in the chromosome and, hence, can be of considerable utility in manipulating the to/wgene in vivo. For example, a gene flanked by directly repeated 34 bp loxP sites and incorporated into the genome by standard gene transfer procedures is efficiently evicted from the chromosome by subsequent expression of the Cre recombinase (8) . Cre catalyzes conservative site specific recombination at the loxP sites to excise the intervening gene, leaving a single loxP site behind in the chromosome. Conversely, prior placement of a lox target in the chromosome allows subsequent targeting of that site by the Cre recombinase (9) . Because Cre directs single copy site-specific integration of a lox targeting vector, isogenic cell lines can be quickly generated to more easily analyze transcriptional regulation or DNA recombination at a particular chromosomal site.
To select for site specific integrants we have used lox fusion vectors that reconstruct a functional, selectable gene after the desired recombinational event (Fig. 1 ). For example, the chromosomal target can be a promoterless, ATG-less lox-neo translational fusion (10) that generates a functional lox-neo fusion gene upon targeted integation of an appropriately designed lox targeting vector (Fig. 1A) . Alternatively, a simple promoter fusion strategy (Fig. IB) can be used in which a promoterless tk gene on the targeting vector is fused to a chromosomally placed promoter by Cre-mediated recombination at loxP sites located 5' to tk and 3' to the promoter, respectively (9) .
For the integration reaction it is important to temporally limit Cre mediated recombination. Integration of the tec targeting vectors requires only transient presence of the Cre recombinase: continuous presence of Cre results in a second round of recombination that removes the targeting vector from the chromosome. Temporally limited expression of die cre gene can be achieved either by placing cre under the transcriptional control of a tightly regulated promoter or by relying on transient expression from a cre expression vector co-transfected with the lox targeting vector. We show here that Cre recombinase activity can be provided by direct introduction of the purified Cre recombinase protein into a variety of cultured cells. Direct introduction of purified Cre recombinase obviates die need for a co-transfecting cre expression vector and thus eliminates the possibility of unwanted incorporation of the cre gene into the genome.
MATERIALS AND METHODS

Cell culture
The thymidine kinase (cfc~) human osteosarcoma cell line 143B, obtained from the American Type Culture Collection, and derivatives were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum. Tk + derivatives were selected in HAT medium (11) . We have observed no spontaneous Tk + derivatives of 143B after examination of more than 1 x 10~9cells. The lox target cell line 14-1-2 (10), a CHO cell derivative, and the lox 2 excision assay cell line 12HG-1 (8), a derivative of the LMtk~ cell line (12) , were cultured in alpha medium and DMEM, respectively, as previously described.
Plasmids and molecular biology
All plasmids were constructed and prepared by standard techniques (13) . The ZoxP-containing plasmid pBS64 (14) , the SV40 pmmot£T-loxP-neo plasmid pBS74 (8) , the loxP-tk targeting vector pBS153 (9) , and die lox translational fusion targeting vectors pBS226 (10) and pSF23 (15) have been described previously. Plasmid pSF23 is identical to pBS226 except that the CMV promoter has been replaced by the 250 bp herpes simplex virus type I tk promoter. A cDNA expression cassette (consisting of the CMV promoter, a mutiple cloning site, and the SV40 polyadenylation signal) was obtained from A. Colberg-Poley (Children's National Medical Center) and inserted 5' to the tk promoter of pSF23, in either the same or opposite orientation with respect to the tk promoter, to give pBS261 and pBS266, respectively. The CMV-lacZ expression plasmid p324 was a gift from A. Colberg-Poley (Children's National Medical Center).
The number of mz/wgenes inserted into the genome after gene transfer of pBS74 into the 143B cell line was determined by quantitative Southern analysis (16) , using a transgene probe and an endogenous genomic probe to normalize for gel loading variability. Briefly, 5 pg genomic DNA from candidate cell lines was digested both with EcoRI and with BamHI, electrophoresed on a 0.8% agarose gel and then blotted to GeneScreen Plus (DuPont Co.). Hybridization was with a neo probe to detect pBS74 and with the human angiotensin Type I receptor gene (a gift from Martha Corjay, DuPont Merck) as the internal control. In addition a titration series of linearized pBS74 corresponding to 1 -64 copies per genome were electrophoresed and blotted in parallel with the genomic samples. The copy number of the transgeae in these cells was determined by densitometry of autoradiograms from both the EcoRI and the BamHI digests.
Gene transfer
A loxP target was incorporated into the genome of 143B cells by microinjection of pBS74 and selecting for resistance to 400 /xg/ml G418. Single cells were microinjected with the ZeissEppendorf AIS Automated Injection System (17) . Plasmid pBS74 contains the SV40 promoter neo cassete with a single loxP site inserted betwen the promoter and the neo gene as shown in Fig. IB . Plasmid pBS74 was linearized by digestion with EcoRI and then approximately 120 individual cells on a glass slide were each injected with a volume of 1 fl containing about 1000 linearized plasmid molecules. Cells were trypsinized 4 hr after injection and replated in 10 cm dishes. Two days after injection cells were selected for resistance to 400 /ig/rnl G418. Twelve G418 resistant transformants were observed 21 days after microinjection. These were picked and expanded for further analysis.
Lipofection of DNA and protein into cultured cells was with TransfectACE™ (Life Technologies, Inc.), a 1:2.5 (w/w) formulation of dimethyl dioctadecylammonium bromide and dioleoyl phosphatidylethanolamine, and was performed essentially as suggested by the manufacturer, with the following modifications. Cells were seeded in a six well tissue culture plate and allowed to reach -80% confluency. DNA and Cre protein (NEN-DuPont Co.) were mixed with Opti-MEM (Life Technologies, Inc.), giving a final volume of 100 /tl, and incubated at 0°C for 5 min. In a separate aliquot, 12 /xl TransfectACE was added to 88 /tl Opti-MEM. The two aliquots were combined and incubated 10 min at room temperature. The volume was brought to 1 ml by addition of Opti-MEM and the mixture then added to a single well of cells that had been previously washed twice with Opti-MEM. Cells were incubated for 5 hr at 37°C, lml of or medium + 20% dialyzed fetal bovine serum was added and incubation was continued overnight. The next day cells were trypsinized and replated. Selection for stable transformants was imposed 48 hr after the lipofection procedure.
RESULTS
Protein mediated targeting
Using the lox-neo fusion system (Fig. 1A) purified Cre protein was introduced with the pBS226 targeting vector (Fig. 2) by means of a lipofection procedure. As demonstrated previously, G418 resistance is diagnostic of Cre-mediated site-specific recombination in this system (10) . Titration of Cre with a constant amount of lox targeting vector (1 /ig) showed optimal targeting (highest frequency of G418 resistance) with 8.4 ng of Cre, and A.
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Promoter /Translation Fusion Simple Promoter Fusion Figure 1 . Cre-mediated integrative recombination. A. Targeted integration using a chromosomal lox-neo fusion target. Upon she-specific recombination of the prcinoter-ATG-izc targeting vector with the chromosomal target (having an inactive neo gene), a functional lox-neo fusion gene is produced to confer G418 resistance on the cell. B. Targeting with a simple promoter lax fusion vector. The chromosomal target is the SV40 promoter-iic-neo fragment from pBS74. The targeting vector, pBS153, has a promoterless tk gene preceded by a loxP she. Cre-mediated recombination at the lox sites places the tk gene under the control of the SV40 promoter and confers HAT resistance. Note that in this binary system the defective structural gene can be either placed in the chromosome (A) or in the targeting vector (B). In both cases Cre-mediated integration results in a lox 2 product that is itself a substrate for excisive recombination. little or no targeting with less than 3 fig Cre (Fig. 3 ). Higher amounts of Cre reduced targeting efficiency. Lipofection procedures require that an optimal amount of DNA (ratio of DNA to lipid) be used in the lipofection procedure. We first determined that 1/tg DNA was optimal for stable (illegitimate) transformation with a SV40neo vector in these cells (data not shown). Because increasing amounts of targeting vector result in increased targeting when co-electroporated with a Cre expression vector (9), we examined targeting efficiency in the lipofection procedure as a function of the amount of targeting vector, holding the amount of Cre protein constant at the optimized level (Fig. 4) .
ATG-tox
Between 1 ana 3 /tg of DNA gave optimal targeting efficiency with the pBS226 targeting vector. For comparison, two other lox targeting vectors were also examined in this assay: pBS261 and pBS266 (Fig. 2) . These two vectors are similar to pBS226, but use the weak HSV-1 tk promoter to drive the lox-neo fusion gene after integration instead of the strong CMV promoter. In addition, both contain a CMV promoter-driven cDNA expression module, but in opposite orientations. Both pBS261 and pBS266 are also proficient in targeting and showed optimal targeting at 1 ng DNA, although at a substantially lower frequency than that seen with pBS226.
Excision
The Cre recombinase catalyzes precise removal of a transgene from the genome (18) . This activity can be used both to eliminate a gene's activity and to activate an adjacent gene. For example, we have previously described (8) a mouse cell line, 12HG-1, in which expression of the neo gene is attenuated by insertion of the yeast LEU2 gene flanked by directly repeated lox sites between the SV40 promoter and the neo structural gene. Cremediated recombination excises the LEU2 gene to regenerate a functional neo expression unit, thus conferring high level G418 resistance.
We tested the ability of purified Cre protein to activate G418 resistance in 12HG-1 cells by excisive Cre-mediated recombination using the lipofection procedure. There is a low spontaneous frequency of G418 resistance with this cell line (Table I ) and, as we had observed previously, this is probably due to occasional amplification of the neo gene (8) . When cells are lipofected with Cre protein there is about a 40 fold stimulation of G418 resistance from excisive recombination so that about 10% of all treated cells become G418 resistant. This is approximately the same fraction of cells that express /3-galactosidase after lipofection with CMV-lacZ DNA. Lipofection of pure Cre protein alone gives high levels of excisive recombination in these cells (Exp. 2, Table 1 ). Co-lipofection of Cre with either tetP-containing DNA (pBS64) or non-toxP DNA (p324) did not facilitate uptake of Cre by cells.
Effect of lox target copy number and position on integrative recombination
Next we examined the effect of position and copy number of the lox targets in the chromosome on the efficiency of Cremediated targeting using the targeting scheme shown in Fig. IB . The tk~ human osteosarcoma cell line 143B was microinjected with plasmid pBS74 containing the SV40 promoter-loxP-neo target sequence and independent G418 resistant colonies were selected. Southern analysis showed that transformants had between 2 and 60 copies of the loxP target, mostly integated as tandem arrays. Representative cell lines are shown in Fig. 5 . The copy number of the loxP target in eight of these cell lines was established by quantitative Southern analysis and the targeting efficiency was then determined for all eight by selecting for Tk + using the loxP-tk targeting vector containing a promoterless HSV-1 tk gene. Three of these cell lines showed a high frequency of targeting, three showed a greater than 10 fold decreased targeting efficiency and two were intermediate (Table II) . These results indicate that targeting efficiency is much more dependent on chromosomal position than on the copy number of loxP. The cell line showing the highest targeting efficiency, 143-3, is one with a lower copy number of the loxP target. Conversely, cell line 143-2 has the highest copy number of loxP targets but shows an intermediate frequency of targeting. The ratio of Tk + transformants to chromosomal loxP copy number varies from 0 to 15 and indicates that there is no simple relation between copy number and targeting efficiency. Thus, Cre-mediated targeting is subject to significant position effects. In particular, certain chromosomal loci are more accessible to site specific recombination than are others. 
DISCUSSION
We show here that active Cre recombinase can be directly introduced into mammalian cells using a lipofection procedure. The lipofected recombinase protein is proficient both for sitespecific excision of DNA from the chromosome and for chromosomal targeted integration of a co-lipofected lox targeting vector. Our results are analogous to those of others who have previously shown the utility of directly introducing proteins into cells, for example, by electroporation, as has been shown for restriction enzymes (19) , antibodies (20) and viral transactivator (21) proteins. In preliminary experiments, we've found that Cre protein can also be electroporated into cells to give site specific recombination (S. Fukushige and B. S., unpublished data).
Direct introduction of Cre recombinase into cells has a number of distinct advantages compared to using cre expression plasmids. First, use of purified protein rather than DNA eliminates the possibility of stable integration of the cre gene. For example, in the construction of targeted knockout mutations in embryonal stem cells it is often desirable to remove the selectable marker gene used to generate the knockout. This can be done by flanking the marker gene by direcdy repeated loxP sites in die targeting construct and later excising the marker gene in the resulting knockout cell line by transient expression of the cre gene (18) . Use of purified Cre protein eliminates the need to check marker gene 'popout' colonies for presence of the cre gene. Second, because direct protein transfer should be possible with many different cell types, there is no need for individualized cre vectors having particular cell and tissue specfic transcription and translation signals. Third, recombinase activity is temporally prescribed by the actual presence of functional Cre protein in the cell, thus averting problems for efficient integration of lox targeting vectors arising from long term persistence (and expression) of DNA, as occurs in certain cells, such as striatal muscle (22) .
The efficiency of Cre-mediated genomic targeting depends in part on the lox targeting vector used. A higher frequency of sitespecific integration occurs with the lox-neo fusion vector having the strong CMV major immediate early promoter driving expression of the fusion than with vectors using the tk promoter to drive expression. Moreover, proximity of the CMV promoter/enhancer to the tk promoter in these latter vectors increases targeting efficiency. This could be due to enhanced recovery of integants from CMV enhanced expression of the loxneo fusion, although selection at reduced concentrations of G418 does not result in increased targeting efficiency (data not shown). A second possibility is that the CMV enhancer potentiates site specific recombination with the chromosome, for example, by keeping the plasmid lox site accessible to Cre protein and to Cremediated synapsis with the chromosomal lox site. This may occur either by keeping the chromatin surrounding the lox site in an accessible configuration, or indirectly by transcription through the site. It has been suggested, for example, that transcription may stimulate homologous recombination in mammalian cells (23) . The efficiency of Cre-mediated genomic targeting is sensitive to chromosomal position effects. We observe a 50-fold difference in targeting efficiency per target lox site in human osteosarcoma cell lines engineered to have variously located lox targets. Previously we noted only marginal differences in targeting efficiency with four CHO cell lines each having a single copy lox target (10) . This prior observation may be explained by the small number of CHO lines examined and by the inherent bias in choosing lines having only a single copy of the lox target and, hence, of the selected marker gene. The cause(s) of position effects on recombination and gene expression is not well understood. It will be interesting to see whether the position effect on Cre-mediated targeting correllates with position effects on transcription or on homologous recombination. Because Cre can direct integration of a series of lox integration vectors to the same target site, and thus construct isogenic cell lines, it should be possible to examine the effect of various DNA sequence motifs on these position effects.
The ability of lipofected Cre protein to catalyze both integrative and excisive site specific recombination in cultured cells has important practical implications. Because of the ease of the procedure, it can be used for transformation of a target cell line with a battery of targeting plasmids to allow rapid generation of a series of isogenic cell lines. Moreover, removal of a marker gene flanked by lox sites is simply accomplished by direct introduction of Cre protein, obviating the possibility of unwanted adventitious integration of a cre expression plasmid. Chromosomal manipulations with purified Cre recombinase should be of particular use in engineering both fertilized zygotes and embryonal stem cells for the production of transgenic mice (18, 25, 26) .
